Publications (2021)

Publication (International Journal)

1. Kawashima A, Kutsuna S, Shimomura A, Suzuki T, Nakamoto T, Ando H, Nagashima M, Inagaki T, Ohmagari N.
   Catheter-related bloodstream infection caused by Tsukamurella ocularis: A case report.
   J Infect Chemother. 2022 Mar;28(3):434-436. doi: 10.1016/j.jiac.2021.11.003. Epub 2021 Nov 18. PMID: 34802889.
2. Kawashima A, Kutsuna S, Shimomura A, Sato L, Ando H, Tanikawa T, Nagashima M, Miyoshi-Akiyama T, Inagaki T, Ohmagari N.
   Streptobacillus notomytis Bacteremia after Exposure to Rat Feces.
   Emerg Infect Dis. 2022 Apr;28(4):886-888. doi: 10.3201/eid2804.204965. PMID: 35318927; PMCID: PMC8962910.
3. Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N(2021).
   “A pilot study of viral load in stools of patients with COVID-19 and diarrhea”.
   Japanese Journal of Infectious Disseases. 2021 May 31.doi: 10.7883/yoken.JJID.2021.018.
4. Akiyama Y, Morioka S, Asai Y, Sato L, Suzuki S, Saito S, Matsunaga N, Hayakawa K, Ohmagari N.
   Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP.
   J Infect Public Health. 2022 Jan 31;15(3):312-314. doi: 10.1016/j.jiph.2022.01.014.
5. Akiyama Y, Ishikane M, Ohmagari N (2021)
   “Epstein-Barr virus induced skin rash in infectious mononucleosis”.
   ID cases. 2021; 26: e01298.
6. Sho Saito, Kayoko Hayakawa, Ayako Mikami, Shinyu Izumi, Hideki Funazaki, Shinobu Ashida, Wataru Sugiura, Haruhito Sugiyama, Norihiro Kokudo, Norio Ohmagari.
   Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.
   Glob Health Med. 2021 Apr 30;3(2):62-66.
7. Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Tomoya Saito, Satoshi Takasago, Masayuki Hojo, Noriko Iwamoto, Norio Ohmagari.
   The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics.
   Glob Health Med. 2022;4(2):133-136.
8. Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, Noriko Kinoshita, Mari Terada, Yusuke Miyazato, Takato Nakamoto, Tetsuya Suzuki, Sho Saito, Mio Endo, Kohei Kanda, Kenji Maeda, Jin Takasaki, Masayuki Hojo, Yukihito Ishizaka, Norio Ohmagari.
   Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
   J Infect Chemother. 2021 Jun;27(6):808-813.
9. Mari Terada, Hiroshi Ohtsu, Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga,Satoshi Kutsuna, Wataru Sugiura, Norio Ohmagari.
   Risk factors for severity on admission and the disease progression during hospitalization in a large cohort of COVID-19 patients in Japan.
   BMJ Open. 2021 Jun 15;11(6):e047007.
10. Andre C Kalil, Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain, Cameron R Wolfe, Guillermo M Ruiz-Palacios, Susan Kline, Justino Regalado Pineda, Anne F Luetkemeyer, Michelle S Harkins, Patrick E H Jackson, Nicole M Iovine, Victor F Tapson, Myoung-don Oh, Jennifer A Whitaker, Richard A Mularski, Catharine I Paules, Dilek Ince, Jin Takasaki, Daniel A Sweeney, Uriel Sandkovsky, David L Wyles, Elizabeth Hohmann, Kevin A Grimes, Robert Grossberg, Maryrose Laguio-Vila, Allison A Lambert, Diego Lopez de Castilla, EuSuk Kim, LuAnn Larson, Claire R Wan, Jessica J Traenkner, Philip O Ponce, Jan E Patterson, Paul A Goepfert, Theresa A Sofarelli, Satish Mocherla, Emily R Ko, Alfredo Ponce de Leon, Sarah B Doernberg, Robert L Atmar, Ryan C Maves, Fernando Dangond, Jennifer Ferreira, Michelle Green, Mat Makowski, Tyler Bonnett, Tatiana Beresnev, Varduhi Ghazaryan, Walla Dempsey, Seema U Nayak, Lori Dodd, Kay M Tomashek, John H Beigel, on behalf of the ACTT-3 study group members.
    Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
    Lancet Respir Med. 2021 Oct 18;S2213-2600(21)00384-2.
11. Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu , Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane.
    Hyperimmune Immunoglobulin for Hospitalized Patients With COVID-19.
    Lancet. 2022 Feb 5;399(10324):530-540.
12. Tetsuya Suzuki, Satoshi Kutsuna, Sho Saito, Akira Kawashima, Ayako Okuhama, Kohei Kanda, Lubna Sato, Makoto Inada, Yutaro Akiyama, Satoshi Ide, Keiji Nakamura, Takato Nakamoto, Kei Yamamoto, Masahiro Ishikane, Noriko Kinoshita, Shinichiro Morioka, Kayoko Hayakawa, Norio Ohmagari.
    Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
    Int J Infect Dis. 2021 May 4;S1201-9712(21)00400-8.
13. Yumi Matsushita, Tetsuji Yokoyama, Kayoko Hayakawa, Nobuaki Matsunaga, Hiroshi Ohtsu, Sho Saito, Mari Terada, Setsuko Suzuki, Shinichiro Morioka, Satoshi Kutsuna, Tetsuya Mizoue, Hisao Hara, Akio Kimura, Norio Ohmagari.
    Smoking, comorbidities, and severity of COVID-19 in hospitalized COVID-19 patients in Japan.
    Int J Epidemiol. 2021 Dec 11:dyab254.
14. Satoshi Ide, Kayoko Hayakawa, Kei Yamamoto, Shinya Tsuzuki, Junko Tanuma, Kaori Ohara, Gen Yamada, Ayako Okuhama, Kohei Kanda, Tetsuya Suzuki, Yutaro Akiyama, Yusuke Miyazato, Keiji Nakamura, Hidetoshi Nomoto, Takato Nakamoto, Mugen Ujiie, Sho Saito, Shinichiro Morioka, Masahiro Ishikane, Noriko Kinoshita, Satoshi Kutsuna, Keiko Tanaka, Norio Ohmagari.
    Positive ratio of polymerase chain reaction (PCR) and validity of pre-screening criteria at an outpatient screening center during the early phase of the COVID-19 epidemic in Japan.
    Jpn J Infect Dis. 2021 Sep 22;74(5):481-486.
15. Mugen Ujiie, Shinya Tsuzuki, Michiyo Suzuki, Masayuki Ota, Tetsuya Suzuki, Hidetoshi Nomoto, Kei Yamamoto, Sho Saito, Akatsuki Kokaze, Noriko Kinoshita.
    Safety of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) in adults in Japan.
    Jpn J Infect Dis. 2021 Sep 22;74(5):399-404.
16. Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, KentaTezuka, Emi Ikebe, Sho Saito, Noriko Kinoshita, Mari Terada, Mio Endo, Tetsuya Suzuki, Yusuke Miyazato, Takato Nakamoto, Makoto Inada, Isao Hamaguchi, Norio Ohmaga.
    No SARS-CoV-2 RNA detection in the convalescent plasma of COVID-19 patients with different disease severity.
    J Infect Chemother. 2021 Apr;27(4):653-655.
17. Gen Yamada, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Hiroshi Ohtsu, Masayuki Hojo, Masao Hashimoto, Kentaro Kobayashi, Ryo Sasaki, Tatsuya Okamoto, Yasuaki Yanagawa, Daisuke Katagiri, Mari Terada, Michiyo Suzuki, Lubna Sato, Yusuke Miyazato, Masahiro Ishikane, Shinichiro Morioka, Sho Saito, Norio Ohmagari.
    External Validation and Update of Prediction Models for Unfavorable Outcomes in Hospitalized Patients with COVID-19 in Japan.
    J Infect Chemother. 2021 Jul;27(7):1043-1050.
18. Mari Terada, Satoshi Kutsuna, Tomiteru Togano, Sho Saito, Noriko Kinoshita, Yumiko Shimanishi, Tetsuya Suzuki, Yusuke Miyazato, Makoto Inada, Takahito Nakamoto, Hidetoshi Nomoto, Satoshi Ide, Mitsuhiro Sato, Kenji Maeda, Akihiro Matsunaga, Masahiro Satake, Keiji Matsubayashi, Hirokazu Tsuno, Makiko Kojima, Madoka Kuramistu, Kenta Tezuka, Emi Ikebe, Kazu Okuma, Isao Hamaguchi, Katsuyuki Shiratori, Motohiko Sato, Yuiko Kawakami, Kumi Inaba, Saori Igarashi, Reina Yamauchi, Mina Matsumura, Keiko Ishimaru, Bijuan Zhang, Chika Kuge, Maiko Ishihara, Miho Gouda, Keiko Tanaka, Yukihito Ishizaka, Norio Ohmagari.
    How we secured a COVID-19 Convalescent Plasma Procurement Scheme in Japan.
    Transfusion. 2021 Jul;61(7):1998-2007.
19. Gen Yamada, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Hiroshi Ohtsu, Ako Toyoda, Koji Kitajima, Shinya Tsuzuki, Sho Saito, Norio Ohmagari.
    Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalization.
    Epidemiol Infect. 2021; 149: e175.
20. Ayako Okuhama, Masatoshi Hotta, Masahiro Ishikane, Akira Kawashima, Yusuke Miyazato, Mari Terada, Gen Yamada, Kohei Kanda, Makoto Inada, Lubna Sato, Mitsuhiro Sato, Yutaro Akiyama, Tetsuya Suzuki, Takato Nakamoto, Hidetoshi Nomoto, Satoshi Ide, Keiji Nakamura, Sho Saito, Noriko Kinoshita, Kei Yamamoto, Shinichiro Morioka, Mugen Ujiie, Kayoko Hayakawa, Satoshi Kustuna, Yoshitaka Shida, Tsuyoshi Tajima, Katsuji Teruya, Yumi Funato, Makiko Yamamoto, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama, Norio Ohmagari.
    Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease.
    J Infect Chemother. 2022 Feb;28(2):217-223.
21. Tetsuya Suzuki, Yusuke Asai, Satoshi Ide, Saori Fukuda, Akihito Tanaka, Yumiko Shimanishi, Kozue Takahashi, Mari Terada, Lubna Sato, Mitsuhiro Sato, Makoto Inada, Gen Yamada, Yusuke Miyazato, Yutaro Akiyama, Hidetoshi Nomoto, Takato Nakamoto, Keiji Nakamura, Tomiteru Togano, Shinichiro Morioka, Noriko Kinoshita-Iwamoto, Sho Saito, Satoshi Kutsuna, Norio Ohmagari.
    Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.
    J Infect Chemother. Feb;28(2):206-210. 2022
22. Satoshi Ide, Sho Saito, Tsubasa kazawa, Takahito Furuya, Junichi Masuda, , Maki Nagashima, , Yusuke Asai, , Tatsunori Ogawa, , Ryohei Yamamoto, Haruhiko Ishioka, , Kohei Kanda, , Ayako Okuhama, , Yuji Wakimoto, Tetsuya Suzuki, Yutaro Akiyama, , Yusuke Miyazato, , Keiji Nakamura, , Takato Nakamoto, , Hidetoshi Nomoto, Yuki Moriyama, Masayuki Ota, Shinichiro Morioka, , Wataru Matsuda, , Tatsuki Uemura, Kentaro Kobayashi, , Ryo Sasaki, Daisuke Katagiri, , Satoshi Kutsuna, , Kayoko Hayakawa, , Norio Ohmagari.
    Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019.
    IDCases. 2021 Nov 17;26:e01343.
23. Yusuke Asai, Hidetoshi Nomoto, Kayoko Hayakawa, Nobuaki Matsunaga, Shinya Tsuzuki, Mari Terada, Hiroshi Ohtsu, Koji Kitajima, Kumiko Suzuki, Tetsuya Suzuki, Keiji Nakamura, Shinichiro Morioka, Sho Saito, Fumitake Saito, Norio Ohmagari.
    Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age Groups in Japan.
    Gerontology. 2022 Jan 7;1-11.
24. Shinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura, Tomohiro Shinozaki, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Koji Kitajima, Sho Saito, Gen Yamada, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari.
    Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
    Int J Infect Dis. 2022 Feb 19;118:119-125.
25. Michiyo Suzuki, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Mari Terada, Hiroshi Ohtsu, Ako Toyoda, Jin Takasaki, Masayuki Hojo, Yasuaki Yanagawa, Sho Saito, Kei Yamamoto, Satoshi Ide, Yutaro Akiyama, Tetsuya Suzuki, Ataru Moriya, Kazuhisa Mezaki, Norio Ohmagari.
    Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan.
    Jpn J Infect Dis. 2022 Feb 28.
26. Shinya Tsuzuki, Kayoko Hayakawa, Yohei Doi, Tomohiro Shinozaki, Yukari Uemura, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Gen Yamada, Sho Saito, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari.
    Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
    Infect Dis Ther. 2022 Mar 21;1-13.
27. Mikako Ueno, Naoko Iwata-Yoshikawa, Akihito Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yuu I. Yaoita, Jun Suzuki, Kenji Sadamasu, Kazuhisa Yoshimura, Satoshi Kutsuna, Nozomi Shiwa-Sudo, Noriyo Nagata, Tadaki Suzuki, Akinori Suzuki, Miwa Okamoto, Moto Kimura, Norio Ohmagari, Ryu Miura, Yukihito Ishizaka.
    Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variant.
    Antiviral Res. 2022 Mar 24;105297.
28. Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Yamada M, Ozawa N, Yamaguchi K, Miyairi I, Ohmagari N.
    Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan.
    Clin Infect Dis. 2022 Jan 17:ciac028.
29. Maruki T, Iwamoto N, Kanda K, Okumura N, Yamada G, Ishikane M, Ujiie M, Saito M, Fujimoto T, Kageyama T, Saito T, Saito S, Suzuki T, Ohmagari N.
    Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
    Clin Infect Dis. 2022 Jan 3:ciab1072.
30. Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Ohmagari N.
    Clinical Characteristics of Hospitalized COVID-19 in Children: Report From the COVID-19 Registry in Japan.
    J Pediatric Infect Dis Soc. 2021 Sep 6:piab085.
31. Okubo Y, Nishi A, Michels KB, Nariai H, Kim-Farley RJ, Arah OA, Uda K, Kinoshita N, Miyairi I.
    The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment.
    Int J Epidemiol. 2022 Mar 30:dyac057.
32. Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Halfmann P, Watanabe S, Maeda K, Imai M, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y.
    Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
    N Engl J Med. 2022 Apr 14;386(15):1475-1477.
33. Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Chiba S, Halfmann P, Nagai H, Saito M, Adachi E, Sullivan D, Pekosz A, Watanabe S, Maeda K, Imai M, Yotsuyanagi H, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y.
    Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
    N Engl J Med. 2022 Mar 10;386(10):995-998.
34. Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N.
    Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.
    J Infect Chemother. 2021 Nov;27(11):1669-1673.
35. Okubo Y, Nariai H, Michels KB, Kim-Farley RJ, Nishi A, Arah OA, Kinoshita N, Uda K, Miyairi I.
    Change in clinical practice variations for antibiotic prescriptions across different pediatric clinics: A Japan's nationwide observational study.
    J Infect Chemother. 2021 Nov;27(11):1621-1625.
36. Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N.
    Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
    Emerg Infect Dis. 2021 Nov;27(11):2969-2970.
37. Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N.
    The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
    J Infect Chemother. 2021 Oct;27(10):1498-1503.
38. Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N.
    Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission"[Int J Infect Dis 104 (2021) 65-72].
    Int J Infect Dis. 2021 Aug;109:323.
39. Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N.
    Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
    J Infect Chemother. 2021 Aug;27(8):1273-1275.
40. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N.
    Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
    J Infect Chemother. 2021 Jul;27(7):1063-1067.
41. Anzurez A, Naka I, Miki S, Nakayama-Hosoya K, Isshiki M, Watanabe Y, Nakamura-Hoshi M, Seki S, Matsumura T, Takano T, Onodera T, Adachi Y, Moriyama S, Terahara K, Tachikawa N, Yoshimura Y, Sasaki H, Horiuchi H, Miyata N, Miyazaki K, Koga M, Ikeuchi K, Nagai H, Saito M, Adachi E, Yotsuyanagi H, Kutsuna S, Kawashima A, Miyazato Y, Kinoshita N, Kouno C, Tanaka K, Takahashi Y, Suzuki T, Matano T, Ohashi J, Kawana-Tachikawa A.
    Association of HLA-DRB1*09:01 with severe COVID-19.
    HLA. 2021 Jul;98(1):37-42.
42. Nishida T, Iwahashi H, Yamauchi K, Kinoshita N, Okauchi Y, Suzuki N, Inada M, Abe K.
    Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
    Medicine (Baltimore). 2021 Jun 25;100(25):e26433.
43. Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K, Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N.
    Clinical course of alopecia after COVID-19.
    Int J Infect Dis. 2021 Jun;107:255-256.
44. Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H.
    Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
    J Clin Apher. 2021 Jun;36(3):313-321.
45. Ogawa T, Uemura T, Matsuda W, Sato M, Ishizuka K, Fukaya T, Kinoshita N, Nakamoto T, Ohmagari N, Katano H, Suzuki T, Hosaka S.
    SARS-CoV-2 Leakage From the Gas Outlet Port During Extracorporeal Membrane Oxygenation for COVID-19.
    ASAIO J. 2021 May 1;67(5):511-516.
46. Khor SS, Omae Y, Nishida N, Sugiyama M, Kinoshita N, Suzuki T, Suzuki M, Suzuki S, Izumi S, Hojo M, Ohmagari N, Mizokami M, Tokunaga K.
    HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
    Front Immunol.2021 Apr 22;12:658570.
47. Kanda K, Kinoshita N, Kutsuna S, Nakamura K, Okuhama A, Shimomura A, Inagaki T, Yoshikawa T, Kurosu T, Shimojima M, Saijo M, Ohmagari N.
    Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage.
    Viruses. 2021 Apr 10;13(4):657.
48. Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, Nishiyama A, Kawana-Tachikawa A, Miki S, Hosoya-Nakayama K, Nakamura-Hoshi M, Seki S, Tachikawa N, Yoshimura Y, Miyata N, Horiuchi H, Sasaki H, Miyazaki K, Kinoshita N, Sudo T, Akiyama Y, Sato R, Suzuki T, Matano T, Takahashi Y.
    Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan.
    Int Immunol. 2021 Mar 31;33(4):241-247.
49. Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H.
    Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
    Sci Rep. 2021 Mar 10;11(1):5563.
50. Yamamoto K, Asai Y, Nakatani I, Hayashi K, Nakagawa H, Shinohara K, Kanai S, Shimatani M, Yamato M, Shimono N, Kitaura T, Komiya N, Nagasaka A, Mikawa T, Manabe A, Matono T, Yamamoto Y, Ogawa T, Kutsuna S, Ohmagari N.
    Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR).
    Trop Dis Travel Med Vaccines. 2022 Feb 1; 8(1):6. doi: 10.1186/s40794-021-00160-4. PMID: 35101123; PMCID: PMC8805374.
51. Motohashi A, Yamamoto K, Mezaki K, Moriya A, Kurokawa M, Oki H, Ando H, Isaka E, Usami A, Ide S, Nakamura K, Nakamoto T, Nomoto H, Ohmagari N.
    Negative Results of Nucleic Acid Amplification Tests for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in Patients with COVID-19.
    Jpn J Infect Dis. 2022 May 24;75(3):309-313. doi: 10.7883/yoken.JJID.2021.416. Epub 2021 Sep 30. PMID: 34588366.
52. Yamamoto K, Mezaki K, Ohmagari N.
    Simple indictor of increased blood culture contamination rate by detection of coagulase-negative staphylococci.
    Sci Rep. 2021 Sep 2;11(1):17538. doi: 10.1038/s41598-021-96997-y. PMID: 34475478; PMCID: PMC8413347.
53. Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H, Ohmagari N.
    Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
    Int J Infect Dis. 2022 Mar 16:S1201-9712(22)00155-2. doi: 10.1016/j.ijid.2022.03.017. Epub ahead of print. PMID: 35306204; PMCID: PMC8925083.
54. Ono A, Koizumi R, Tsuzuki S, Asai Y, Ishikane M, Kusama Y, Ohmagari N.
    Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Int J Infect Dis. 2022 Mar 16:S1201-9712(22)00157-6. doi: 10.1016/j.ijid.2022.03.019. Epub ahead of print. PMID: 35306203; PMCID: PMC8926437.
55. Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N.
    Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Emerg Infect Dis. 2022 Mar 15;28(5). doi: 10.3201/eid2805.220197. Epub ahead of print. PMID: 35290176.
56. Beppu H, Ogawa T, Ishikane M, Kawanishi T, Fukuda T, Sato L, Matsunaga A, Maeda K, Katagiri D, Ishizaka Y, Mitsuya H, Ohmagari N, Yasui F, Kohara M, Kikuchi K, Wakai S.
    A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
    CEN Case Rep. 2022 Mar 9:1–6. doi: 10.1007/s13730-022-00697-z. Epub ahead of print. PMID: 35266095; PMCID: PMC8906520.
57. Ishikane M, Kubota　H, Moriya A, Kutsuna S, Ando H, Kaburagi Y, Suzuki T, Iwamoto N, Kimura M, Ohmagari N.
    Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, a Rapid Multiplex PCR Method for the Diagnosis of COVID-19.
    J Infect Chemother. 2022. Available online 9 February
58. Miyazato Y, Yamamoto K, Yamada G, Kubota S, Ishikane M, Sugiyama M, Ueno M, Matsunaga A, Miyoshi-Akiyama T, Ishizaka Y, Ohmagari N.
    Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.
    Emerg Infect Dis. 2022 Feb 11;28(4). doi: 10.3201/eid2804.212585. Epub ahead of print. PMID: 35148495.
59. Suzuki T, Morioka S, Nomoto H, Takaya S, Ishikane M, Yanagisawa S, Hayakawa K, Ohmagari N.
    Disseminated Streptococcus anginosus invasive infection with intracranial subdural abscess formation.
    J Infect Chemother. 2022 Jan 9:S1341-321X(21)00352-4. doi: 10.1016/j.jiac.2021.12.016. Epub ahead of print. PMID: 35016822.
60. Inose R, Muraki Y, Kamimoto Y, Kusama Y, Koizumi R, Yamasaki D, Ishikane M, Tanabe M, Ohmagari N.
    The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
    J Infect Chemother. 2022 Feb;28(2):356-358. doi: 10.1016/j.jiac.2021.12.004. Epub 2021 Dec 13. PMID: 34916136.
61. Nomoto H, Ishikane M, Lee S, Komiya N, Maeki T, Matsui T, Morita K, Oshitani H, Saijo M, Yamagishi T, Yamamoto T, Ohmagari N.
    Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study.
    J Infect Chemother. 2022 Jan;28(1):41-46. doi: 10.1016/j.jiac.2021.09.015. Epub 2021 Oct 8. PMID: 34635449.
62. Nakanishi T, Inose R, Kusama Y, Ishikane M, Kajihara T, Yahara K, Sugai M, Ohge H, Ohmagari N, Muraki Y.
    The Use of Topical Antibiotics Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017.
    Jpn J Infect Dis. 2022 Mar 24;75(2):177-182. doi: 10.7883/yoken.JJID.2021.450. Epub 2021 Sep 30. PMID: 34588368.
63. Banno M, Tsujimoto Y, Ishikane M.
    Need for More Randomized Controlled Trials With Rigorous Methodology to Confirm That Ivermectin Is Not a Viable Option for the Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2022 Mar 23;74(6):1121-1122. doi: 10.1093/cid/ciab689. PMID: 34358296; PMCID: PMC8385944.
64. Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J, Yoshimura K, Ohmagari N.
    A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea.
    Jpn J Infect Dis. 2022 Jan 24;75(1):36-40. doi: 10.7883/yoken.JJID.2021.018. Epub 2021 May 31. PMID: 34053956.
65. Nakanishi T, Inose R, Kusama Y, Ishikane M, Kajihara T, Yahara K, Sugai M, Ohge H, Ohmagari N, Muraki Y.
    The use of topical antibiotics based on National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017.
    Jpn J Infect Dis. 2021 Sep 30. doi: 10.7883/yoken.JJID.2021.450. Epub ahead of print. PMID: 34588368.
66. Maruki T, Ishikane M, Suzuki T, Ujiie M, Katano H, Ohmagari N.
    A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
    Int J Infect Dis. 2021 Sep 26;113:55-57. doi: 10.1016/j.ijid.2021.09.055. Epub ahead of print. PMID: 34587536; PMCID: PMC8467371.
67. Hikida S, Morioka S, Fujii N, Tajima T, Terayama Y, Sugiura Y, Ishikane M, Takasaki J, Hojo M, Ohmagari N.
    A single-center descriptive study of untraced sources of infection among new cases of coronavirus disease in Tokyo, Japan.
    Glob Health Med. 2021 Aug 31;3(4):236-239. doi: 10.35772/ghm.2021.01092. PMID: 34532604; PMCID: PMC8403258.
68. Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S, Ohmagari N.
    Clinical and radiological findings of silent hypoxia among COVID-19 patients.
    J Infect Chemother. 2021 Oct;27(10):1536-1538. doi: 10.1016/j.jiac.2021.07.002. Epub 2021 Jul 8. PMID: 34294527; PMCID: PMC8264520.
69. Ebisui A, Inose R, Kusama Y, Koizumi R, Kawabe A, Ishii S, Goto R, Ishikane M, Yagi T, Ohmagari N, Muraki Y.
    Trends in Antipseudomonal Agent Use Based on the 2006 to 2015 Sales Data in Japan.
    Biol Pharm Bull. 2021;44(6):816-821. doi: 10.1248/bpb.b21-00004. PMID: 34078813.
70. Ide S, Ishikane M, Ohmagari N.
    Antimicrobials-induced esophageal ulcer.
    IDCases. 2021 Apr 17;24:e01128. doi: 10.1016/j.idcr.2021.e01128. PMID: 33981580; PMCID: PMC8085691.
71. Kusama Y, Muraki Y, Tanaka C, Koizumi R, Ishikane M, Yamasaki D, Tanabe M, Ohmagari N.
    Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.
    PLoS One. 2021 May 11;16(5):e0251299. doi: 10.1371/journal.pone.0251299. PMID: 33974635; PMCID: PMC8112693.
72. Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo N.
    Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19.
    Glob Health Med. 2021 Apr 30;3(2):115-118. doi: 10.35772/ghm.2020.01093. PMID: 33937576; PMCID: PMC8071681.
73. Ide S, Ishikane M, Ohmagari N.
    Posterior auricular lymphadenopathy in adult rubella.
    IDCases. 2021 Mar 30;24:e01093. doi: 10.1016/j.idcr.2021.e01093. PMID: 33898252; PMCID: PMC8056234.
74. Moriyama Y, Ishikane M, Kusama Y, Matsunaga N, Tajima T, Hayakawa K, Ohmagari N.
    Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan.
    BMC Infect Dis. 2021 Apr 16;21(1):355. doi: 10.1186/s12879-021-06035-5. PMID: 33858346; PMCID: PMC8050890.
75. Hamada Y, Kasai H, Suzuki-Ito M, Matsumura Y, Doi Y, Hayakawa K.
    Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function. 
    Antibiotics (Basel). 2022 Mar 28;11(4):456.
76. Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N.
    Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study. 
    Lancet Reg Health West Pac. 2022 Mar 16;22:100421.
77. Hiroi Y, Ohtsu H, Uemura Y, Hayakawa K, Asai Y, Kutsuna S, Terada M, Sugiura W, Ohmagari N.
    Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020.
    Circ J. 2022 Feb 25;86(3):464-471.
78. Suzuki T, Morioka S, Nomoto H, Takaya S, Ishikane M, Yanagisawa S, Hayakawa K, Ohmagari N.
    Disseminated Streptococcus anginosus invasive infection with intracranial subdural abscess formation. 
    J Infect Chemother. 2022 May;28(5):696-698.
79. Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N.
    Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan. 
    J Infect Chemother. 2022 Feb;28(2):224-231.
80. Hamada Y, Matsumura Y, Nagashima M, Akazawa T, Doi Y, Hayakawa K.
    Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli.
    J Infect Chemother. 2021;27(11):1602-1606.
81. Ide S, Kutsuna S, Yamada G, Hashimoto K, Abe M, Nagi M, Ujiie M, Hayakawa K, Ohmagari N.
    Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.
    J Infect Chemother. 2021;27(11):1658-1661.
82. Tajima T, Asai Y, Endo M, Suzuki T, Matsunaga N, Tsuzuki S, Hayakawa K, Ohmagari N.
    Rate of blood culture submissions in Japan as an indicator of bloodstream infections.
    J Infect Chemother. 2021;27(8):1270-1272.
83. Yamamoto N, Koizumi Y, Tsuzuki S, Ejima K, Takano M, Iwami S, Mizushima D, Oka S.
    Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan.
    Sci Rep . 2022 Feb 23;12(1):3088. doi: 10.1038/s41598-022-07116-4.
84. Ujiie M, Kitano T, Tsuzuki S.
    Changing trends in HPV vaccination in Japan.
    Hum Vaccin Immunother. 2021 Oct 7:1-3. doi: 10.1080/21645515.2021.1986333.
85. Iwanami S, Ejima K, Kim KS, Noshita K, Fujita Y, Miyazaki T, Kohno S, Miyazaki Y, Morimoto S, Nakaoka S, Koizumi Y, Asai Y, Aihara K, Watashi K, Thompson RN, Shibuya K, Fujiu K, Perelson AS, Iwami S, Wakita T.
    Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
    PLoS Med. 2021 Jul 6;18(7):e1003660. doi: 10.1371/journal.pmed.1003660.
86. Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y.
    Evaluation of high-sensitivity cardiac troponin T levels in Japanese patients recently recovered from Coronavirus disease 2019.
    Circulation Journal. 2021 May 25;85(6):944-947. doi: 10.1253/circj.CJ-21-0219.
87. Ono A, Aoyagi K, Muraki Y, Asai Y, Tsuzuki S, Koizumi R, Azuma T, Kusama Y, Ohmagari N.
    Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study.
    BMC Infect Dis. 2021 Sep 21;21(1):983. doi: 10.1186/s12879-021-06688-2.
88. Tsuzuki S, Jiefu Y, Matsunaga N, Ohmagari N.
    Length of stay, hospitalisation cost and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Public Health. 2021 Sep 7;198:292-296. doi: 10.1016/j.puhe.2021.07.046.
89. Tsuzuki S, Matsunaga N, Yahara K, Shibayama K, Sugai M, Ohmagari N.
    Disease burden of bloodstream infections caused by antimicrobial resistant bacteria: a population-level study—Japan, 2015-2018.
    Int J Infect Dis. 2021 May 13;108:119-124. doi: 10.1016/j.ijid.2021.05.018.
90. Morioka S, Gu Y, Tsuzuki S, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N.
    Determinants of clinic doctors’ attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.
    J Infect Chemother. 2021 Feb;27(2):131-138. doi: 10.1016/j.jiac.2020.11.017.
91. Kutsuna S, Asai Y, Yamamoto K, Shirano M, Konishi K, Asaoka T, Yamato M, Katsuragi Y, Yamamoto Y, Sahara T, Tamiya A, Nakamura-Uchiyama F, Sakamoto N, Kosaka A, Washino T, Hase R, Mito H, Kuraita T, Shinohara K, Shimizu T, Kodama F, Nagasaka A, Ogawa T, Kasahara K, Yoshimura Y, Tachikawa N, Yokota K, Murai NSY, Sakamaki I, Hasegawa C, Yoshimi Y, Toyoda K, Mitsuhashi T, Ohmagari N.
    Epidemiogogical trends of imported infectious disease in Japan: Aanlysis of imported 2-year infectious disease registry data.
    J Infect Chemother. 2021 Apr;27(4):632-638. doi: 10.1016/j.jiac.2020.11.028.
92. Koizumi R, Kusama Y, Asai Y, Gu Y, Muraki Y, Ohmagari N.
    Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials.
    BMC Health Serv Res. 2021 Oct 19;21(1):1118. doi: 10.1186/s12913-021-07139-z.
93. Yoshiaki Gu, Yumiko Fujitomo, Rie Takahashi, Norio Ohmagari.
    Japan's first online media seminar on antimicrobial resistance.
    GHM Open Volume 1. Tokyo. 2021. Issue 1(36-37)
94. Yoshiaki Gu, Yumiko Fujitomo, Norio Ohmagari.
    Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).
    Antibiotics (Basel). 2021 Oct 22;10(11):1293.
95. Miyazato Y, Tsuzuki S, Morioka S, Terada M, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Akashi M, Kuge C, Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N.
    Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.
    Journal of Infection and Chemotherapy. In press in April 2022.
96. Matsunaga A, Tsuzuki S, Morioka S, Ohmagari N, Ishizuka Y.
    Long COVID: current status in Japan and knowledge about its molecular background.
    Globan Health and Medicine. 2022;4(2):83-93.
97. Morioka S, Tan BH, Kikuchi H, Asai Y, Suzuki T, Ashida S, Kutsuna S, Saito S, Hayakawa K, Tan TT, Ohmagari N.
    Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan.
    Frontiers in Psychiatry 13:781796. doi: 10.3389/fpsyt.2022.781796.
98. Morioka S, Kurosu H, Kutsuna S, Sato M, Kunimitsu T, Koshiba M, Ohmagari N.
    Building an effective infection prevention and control system in Japan: a historical review. Institutional Repository for Information Sharing.
    World Health Organization. In press in June, 2021.
99. Yamamoto S, Fukunaga A, Tanaka A, Takeuchi J, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Shagari N.
    Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
    Vaccine. 2022;40:1924-1927.
100. Ujiie M.
     Deaths due to dengue in Japanese travellers.
     J Travel Med. 2021 Jul 7;28(5):taab076.
101. Fujino T, Nomoto H, Kutsuna S, Ujiie M, Suzuki T, Sato R, Fujimoto T, Kuroda M, Wakita T, Ohmagari N.
     Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
     Emerg Infect Dis. 2021 Apr;27(4):1243-1245.
102. Butler MS, Gigante V, Sati H, Paulin S, Al-Sulaiman L, Rex JH, Fernandes P,Arias CA, Paul M, Thwaites GE, Czaplewski L, Alm RA, Lienhardt C, Spigelman M,Silver LL, Ohmagari N, Kozlov R, Harbarth S, Beyer P.
     Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
     Antimicrob Agents Chemother. 2022 Mar15;66(3):e0199121.
103. Morita C, Suzuki M, Izumi S, Tsukada A, Tsujimoto Y, Sakamoto K, Hashimoto M,Takasaki J, Ohmagari N, Hojo M.
     Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections.
     Respir Investig. 2022 Mar;60(2):241-247.
104. Kawamoto Y, Kaku N, Akamatsu N, Sakamoto K, Kosai K, Morinaga Y, Ohmagari N, Izumikawa K, Yamamoto Y, Mikamo H, Kaku M, Oishi K, Yanagihara K.
     The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan.
     Int J Antimicrob Agents. 2022 Jan;59(1):106480.
105. Simmons B, Ariyoshi K, Ohmagari N, Pulcini C, Huttner B, Gandra S, Satta G, Moja L, Sharland M, Magrini N, Miraldo M, Cooke G.
     Progress towards antibiotic use targets in eight high-income countries.
     Bull World Health Organ. 2021 Aug 1;99(8):550-561.
106. Imai M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, Chiba S, Watanabe T, Nakajima N, Ito M, Kuroda M, Kiso M, Maemura T, Takahashi K, Loeber S, Hatta M, Koga M, Nagai H, Yamamoto S, Saito M, Adachi E, Akasaka O, Nakamura M, Nakachi I, Ogura T, Baba R, Fujita K, Ochi J, Mitamura K, Kato H, Nakajima H, Yagi K, Hattori SI, Maeda K, Suzuki T, Miyazato Y, Valdez R, Gherasim C, Furusawa Y, Okuda M, Ujie M, Lopes TJS, Yasuhara A, Ueki H, Sakai-Tagawa Y, Eisfeld AJ, Baczenas JJ, Baker DA, O'Connor SL, O'Connor DH, Fukushi S, Fujimoto T, Kuroda Y, Gordon A, Maeda K, Ohmagari N, Sugaya N, Yotsuyanagi H, Mitsuya H, Suzuki T,Kawaoka Y.
     Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
     Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2106535118.
107. Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto , Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y.
     The Japanese Medical Science Federation COVID-19 Expert Opinion English Version.
     JMA J. 2021 Apr 15;4(2):148-162.
108. Hashimoto T, Shiojiri D, Ohmagari N.
     A Retrospective Study of the Optimal Number of Blood Cultures at a Hospital in Japan.
     Tohoku J Exp Med. 2021 Apr;253(4):233-239.
109. Rodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack S, Laxminarayan R, Plant L.
     Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.
     Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129.
110. Miki T, Yamamoto S, Inoue Y, Fukunaga A, Islam Z, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
     Association between living with others and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic.
     Psychiatry Clin Neurosci. 2021 Apr;75(4):148-149.
111. Kamata K, Jindai K, Ide K, Funaki T, Saito H, Takeshita N, Ohmagari N, Hinoshita E, Asanuma K.
     The Flight Evacuation Mission for COVID-19 from Wuhan, China to Tokyo, Japan from January 28 to February 17, 2020.
     Jpn J Infect Dis. 2021 Jul 21;74(4):373-376.
112. Nishida N, Sugiyama M, Kawai Y, Naka I, Iwamoto N, Suzuki T, Suzuki M, Miyazato Y, Suzuki S, Izumi S, Hojo M, Tsuchiura T, Ishikawa M, Ohashi J, Ohmagari N, Tokunaga K, Mizokami M.
     Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
     Sci Rep. 2022 Mar 9;12(1):3854.
113. Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Miyo K, Sugiura W, Sugiyama H, Ohmagari N.
     Sex-associated differences between BMI and SARS-CoV-2 antibody titers following the BNT162b2 vaccine.
     Obesity (Silver Spring). 2022 May;30(5):999-1003.
114. Miki T, Yamamoto S, Fukunaga A, Inoue Y, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
     Association between eating balanced meals and depressive symptoms in Japanese hospital workers during the COVID-19 pandemic.
     Neuropsychopharmacol Rep. 2022 Mar;42(1):109-113.
115. Chujo D, Kurokawa T, Kawabe A, Takahashi N, Inagaki F, Shinohara K, Hagiwara S, Edamoto Y, Ohmagari N, Hinoshita F, Tajima T, Kajio H, Ohtsu H, Takemura N, Matsumoto S, Shimoda M.
     Allogeneic islet transplantation with monitoring of islet-specific cellular autoimmunity in a Japanese patient with type 1 diabetes: A case report.
     J Diabetes Investig. 2022 Apr;13(4):741-745.
116. Lee S, Ishizuka A, Tachimori H, Uechi M, Akashi H, Hinoshita E, et al.
     Japan's development cooperation for health in Vietnam: a first holistic assessment on Japan's ODA and non-ODA public resources cooperation.
     BMC public health. 2021;21(1):2175.

 Presentations at International Conferences and Forums

1. Sho Saito, et al.
   Distribution and associated mortality in carbapenem-resistant gram-negative bacilli in Japan: A multicenter study from Multi-Drug Resistant organisms
   clinical research network (MDRnet), 2021 IDweek, (poster)
2. Kei Yamamoto.
   Diagnostic Performance and Clinical Significance of Clinical Tests: COVID-19 Diagnostic Algorithm, The 12th NCGM International Infectious Diseases Forum, June 7, 2021.
3. GOARN派遣帰国報告会第3回オンラインセミナー（パプワニューギニア） (2022年3月, Web)
4. WHO. BioHub Consultation (2022年3月, Web)
5. GOARN. Global Meeting of Partners 2021. (2021年12月, Web)
6. Cases of Adverse Events of COVID-19 Vaccination. Ad-hoc Panel of MIRE on COVID-19. (2021年11月, Web)
7. Koizumi R, Ishikane M, Kusama Y, Tsuzuki S, Asai Y, Shimada Y, Tanaka C, Ohno A, Kaneko A, Ohmagari N.
   National Cross-Sectional Study of Factors Influencing the Decision of Prescribing Penicillin as First Choice among Dentists in Japan.
   IDWeek2021 (Virtual. Oct 2021) (Poster)
8. Morioka S.
   A overview of Long-COVID research in Japan.
   (Oral presentation in the CRN North Thames Long-COVID National Landscape Webinar on February 16, 2022.)
9. Morioka S.
   Challenges and difficulties in COVID-19 patient care, and necessary approaches in palliative care.
   (Oral presentation at the 14th Asia Pacific Hospice Conference 2021, Kobe, Japan on November 13th, 2021.)
10. Suzuki K.
    Prevalence of healthcare-associated infections and antimicrobial use in "Ryoyo" wards, stratified long-term care beds in Japanese long-term care facilitiese: a point prevalence survey .
    ECCMID2021(2021.7)(Poster)
11. Tsuzuki S.
    Length of stay, hospitalisation cost, and in-hospital fatalities from methicillin-susceptible and -resistant Staphylococcus aureus bacteraemia in a Japanese tertiary care hospital
    ECCMID2021(2021.7)
12. Koizumi R, Kusama Y, Asai Y, Gu Y, Muraki Y, Ohmagari N.
    Impact of a Nationwide Cefazolin Shortage on Antimicrobial Supply in Japan.
    ECCMID 2021, Austria (On Web)
13. Ono A., Aoyagi K., Muraki, Y., Asai, Y., Tsuzuki S., Koizumi R., Azuma T., Kusama Y., & Ohmagari N. (2021).
    Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study.
    ECCMID 2021, Austria (On Web)
14. Koizumi R, Ishikane M, Kusama Y, Tsuzuki S, Asai Y, Shimada Y, Tanaka C, Ono A, Kaneko A, Ohmagari N.
    National Cross-Sectional Study of the Factors on Decision Making of Penicillin Prescription as First Choice among Dentists in Japan.
    IDWEEK2021 (OnWeb)

Review Article

1. Yamamoto K, Ohmagari N.
   Microbiological Testing for Coronavirus Disease 2019.
   JMA J. 2021 Apr 15;4(2):67-75. doi: 10.31662/jmaj.2021-0012. Epub 2021 Apr 2. PMID: 33997438; PMCID: PMC8119126.